Transcript Module 2: The Science of Addiction

NIDA/SAMHSA
Blending Initiative
Overview
Advances in science are
giving us a broad range of
promising options for
treating substance use
disorders, BUT we must
work to ensure that they
actually can be used in
practice and are used in
practice.
• A 17-year gap exists between the
publication of research results and
impact on treatment delivery*
• To reduce the gap, NIDA and
SAMHSA/CSAT have partnered to
disseminate research findings for
application in the treatment
community through the Blending
Initiative
* Lamb, S., Greenlick, M.R., & McCarty, D., Eds. (1998). Bridging the gap between practice
and research: Forging partnerships with community-based drug and alcohol treatment.
Institute of Medicine, National Academy Press: Washington, DC.
What is the Blending Initiative?
• A collaboration between NIDA and
CSAT’s Addiction Technology Transfer
Center (ATTC) Network begun in 2001
• An innovative effort to make the best
substance use disorders treatments
available to those who need them
Blending Initiative Goal
• To harness the skills, resources, and
knowledge of NIDA and SAMHSA to
facilitate moving important scientific
findings into mainstream substance use
disorders treatment practice
A Landmark Initiative
Tools facilitating the dissemination of
research-based practices
are being made available at nearly the
same time that the research results are
published in peer-reviewed journals.
Blending Process
CTN protocols &
other NIDA
research
Hand-Off Meeting
– create the charge for Blending Team,
based on research results and how it can address
critical needs in the treatment field
Blending Team
– develop dissemination strategies and products.
Each team composed of NIDA researchers,
community-based substance abuse treatment practitioners
and staff from SAMHSA's
Addiction Technology Transfer Center (ATTC) Network
Current Blending Packages
Five Blending Packages So Far
1. Buprenorphine Treatment: Training for
Multidisciplinary Addiction Professionals
2. Short-Term Opioid Withdrawal Using
Buprenorphine
3. Treatment Planning M.A.T.R.S.: Utilizing the
Addiction Severity Index (ASI)
4. Motivational Interviewing Assessment:
Supervisory Tools for Enhancing Proficiency
(MIA: STEP)
5. Promoting Awareness of Motivational
Incentives (PAMI)
Buprenorphine Treatment:
Training for Multidisciplinary
Addiction Professionals
Buprenorphine and Buprenorphine/Naloxone
Help Patients Quit Opiate Abuse
http://www.nida.nih.gov/NIDA_notes/NNvol19N3/Successful.html
Goal: to
disseminate
information and
enhance
awareness among
multi-disciplinary
addiction
professionals about
buprenorphine
treatment
Buprenorphine Treatment:
Training for Multidisciplinary
Addiction Professionals
• Products in Package:
– 6-hour classroom training including a
training manual, PowerPoint slides, and the
short movie, “Put Your Smack Down! A
Video About Buprenorphine”
– Annotated bibliography and research articles
Short-Term Opioid Withdrawal
Using Buprenorphine
Goal: The key purpose of this Blending Team
products is to instruct treatment providers
about the 13-day buprenorphine intervention.
Short-Term Opioid Withdrawal
Using Buprenorphine
• Product:
– 4-hour classroom training program including
PowerPoint slides and a CD
Treatment Planning M.A.T.R.S:
Utilizing the Addiction Severity
Index (ASI)
Goal: to transform
required treatment
planning "paperwork"
into clinically useful
information.
Treatment Planning M.A.T.R.S:
Utilizing the Addiction Severity
Index (ASI)
• Products:
– 6-hour classroom training program including
a trainer script and notes, PowerPoint slides,
handouts, and a reference list
– 4-week online course based on the
classroom training
Motivational Interviewing
Assessment: Supervisory Tools
for Enhancing Proficiency
(MIA: STEP)
Goals: to enhance the MI skills of
treatment providers and to fortify
supervisors’ abilities to provide more
structured, focused, and effective
clinical supervision.
Motivational Interviewing
Assessment: Supervisory Tools
for Enhancing Proficiency
(MIA: STEP)
Products include briefing
materials, a MI
Assessment protocol,
teaching tools for
assessing and enhancing
MI skills, supervisor tape
rating guide, demonstration
materials, and a supervisor
training curriculum
Promoting Awareness of
Motivational Incentives (PAMI)
Goal: to inform the field about successful
approaches in the use of motivational
incentives.
Promoting Awareness of
Motivational Incentives (PAMI)
• Products include a training video, a
PowerPoint presentation, a brochure and
a CD of resources
Outcomes
The ATTC Network has:
• Held 326 Blending Product Trainings from
January 2005 – December 2007 as follows:
– 72 Buprenorphine Treatment
– 32 Motivational Interviewing Assessment
(MIA:STEP)
– 95 Promoting Awareness of Motivational Incentives
(PAMI)
– 25 Short Term Opioid Withdrawal Using
Buprenorphine
– 103 Treatment Planning MATRS
The ATTC Network has:
• Printed and distributed 40,000 brochures
introducing each of the Blending Initiatives
materials to the field
• Recruited and prepared trainers in every ATTC
Region to teach the Blending Initiative
materials
• Developed and distributed ancillary products to
enhance the reach of the official NIDA
products, such as curriculum infusion
packages for addiction studies educators at
colleges and universities.
The ATTC Network has:
• Presented information and training on the
protocols included in the Blending
Initiative at NIDA Clinical Trials Network
meetings, NIDA Blending Conferences,
and other NIDA-sponsored events.
• Presented at State, Regional, and
National conferences not affiliated with
either the ATTC or NIDA on the Blending
Initiative protocols.
New Blending Products
Guide to Selecting,
Evaluating, and Utilizing
Evidence-Based Practices
• Coming Summer 2008
• A guide for providers on evidence-based
practices is currently in development.
This guide is designed to help
practitioners in the substance use
disorders treatment field understand what
evidence-based practices are and how to
select and use them.
Update of Buprenorphine
Blending Product
• A preliminary meeting of representatives of the
ATTCs, the NIDA Clinical Trials Network, and
NIDA and CSAT staff was held on February
28, 2008.
• Based on review of the findings of the CTN
research on the use of buprenorphine with
adolescents and young adults, a tentative
decision was made to update the current
buprenorphine blending product with new
research citations and to add a module on the
use of buprenorphine with young adults, aged
18-25.
To Download Blending Initiative
Products
• ATTC National Office
– Click to www.ATTCnetwork.org; Select
NIDA/SAMHSA Blending Initiative from
the “Quick Links” menu
– Or contact 816-235-6888;
[email protected]
• NIDA Web site
www.nida.nih.gov/Blending/index.html